FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Sequana Medical NV's FCF Yield % or its related term are showing as below:
SQNMF'
s FCF Yield % Range Over the Past 10 Years
Min: -185.34 Med: -24.38 Max: -9.49
Current: -37.04
During the past 11 years, the highest FCF Yield % of Sequana Medical NV was -9.49%. The lowest was -185.34%. And the median was -24.38%.
SQNMF's FCF Yield % is ranked worse than 89.63% of 858
companies
in the Medical Devices & Instruments industry
Industry Median: -0.445
vs SQNMF: -37.04
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Sequana Medical NV FCF Yield % Related Terms
Sequana Medical NV FCF Yield % Historical Data
* Premium members only.
The historical data trend for Sequana Medical NV's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sequana Medical NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sequana Medical NV FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Sequana Medical NV's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sequana Medical NV (SQNMF) has a FCF Yield % of -37.04 as of Jul. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Sequana Medical NV and its competitors. According to the industry distribution chart, Sequana Medical NV ranks #769 out of 858 companies in the Medical Devices & Instruments industry, placing it in the top 89.6%.
Is Sequana Medical NV's FCF Yield % too high?
Sequana Medical NV's current FCF Yield % is -37.04. Based on the distribution chart, Sequana Medical NV ranks #769 out of 858 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sequana Medical NV has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Sequana Medical NV's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sequana Medical NV ranks #769 out of 858 companies for FCF Yield %. This places Sequana Medical NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Sequana Medical NV and its competitors. Sequana Medical NV's current FCF Yield % is -37.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sequana Medical NV stock overvalued right now?
Sequana Medical NV (SQNMF) has a current FCF Yield % of -37.04. The stock's GF Value™ is $0.48, compared to a current price of $1.22 — trading 154.2% above its estimated fair value. The current FCF Yield % is -37.04. Sequana Medical NV's overall GF Score™ is 29/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Sequana Medical NV (SQNMF), the current FCF Yield % is -37.04 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sequana Medical NV (SQNMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued.
The current stock price of $1.22 is trading 154.2% above its estimated GF Value™ of $0.48.
Key valuation signals for SQNMF:
FCF Yield %: -37.04
GF Value™: $0.48 vs. price of $1.22 (154.2% above fair value)
No single metric tells the full story. See the SQNMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
29GF Score
Get the complete analysis for SQNMF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SQNMF has been successfully added to your 
